Location: Japan, Kanagawa Prefecture, Fujisawa
Employees: 11-50
Founded date: 2017
Investors 2
Date | Name | Website |
- | Takeda Ven... | takeda.com |
- | New Life S... | new-lifesc... |
Mentions in press and media 1
Date | Title | Description |
07.06.2022 | Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting | KANAGAWA, Japan, June 7, 2022 /PRNewswire/ -- Chordia Therapeutics Inc. ("Chordia"), a biotech company engaged in the research and development of novel therapies for cancers, today announced that it has presented the interim resul... |